Carol Conrad

Publications

• Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs Makam Megha, Diaz D, Laval J, Gernez Y, Conrad CK. Proc Natl Acad Sci. 2009; 106 (14): 5779
• Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Makam M, Diaz D, Laval J, Gernez Y, Conrad CK, Dunn CE, Davies ZA, Moss RB, Herzenberg LA, Herzenberg LA, Tirouvanziam R. Proc Natl Acad Sci U S A. 2009; 106 (14): 5779-83
• Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation. Danziger-Isakov LA, Worley S, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Michaels MG, Michelson P, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet S, Faro A. J Heart Lung Transplant. 2008; 27 (6): 655-61
• Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, Dunn CE, Davies ZA, Herzenberg LA, Herzenberg LA. Proc Natl Acad Sci U S A. 2008; 105 (11): 4335-9
• American Society of Transplantation executive summary on pediatric lung transplantation. Faro A, Mallory GB, Visner GA, Elidemir O, Mogayzel PJ, Danziger-Isakov L, Michaels M, Sweet S, Michelson P, Paranjape S, Conrad C, Waltz DA. Am J Transplant. 2007; 7 (2): 285-92
• Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety. Geller DE, Konstan MW, Smith J, Noonberg SB, Conrad C. Pediatr Pulmonol. 2007; 42 (4): 307-13
• Risk factors for small bowel bacterial overgrowth in cystic fibrosis. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. J Pediatr Gastroenterol Nutr. 2007; 44 (2): 212-8
• Variability in immunization guidelines in children before and after lung transplantation. Benden C, Danziger-Isakov LA, Astor T, Aurora P, Bluemchen K, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Michaels MG, Mogayzel PJ, Mueller C, Parakininkas D, Oberkfell D, Solomon M, Boehler A. Pediatr Transplant. 2007; 11 (8): 882-7
• High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Tirouvanziam R, Conrad CK, Bottiglieri T, Herzenberg LA, Moss RB, Herzenberg LA. Proc Natl Acad Sci U S A. 2006; 103 (12): 4628-33
• Does bacterial colonization play a role in acute respiratory failure in chronic obstructive pulmonary disease? Conrad C, Crit Care Med. 2005; 33 (9): 2130-1
• Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome. Sheridan MB, Fong P, Groman JD, Conrad C, Flume P, Diaz R, Harris C, Knowles M, Cutting GR. Hum Mol Genet. 2005; 14 (22): 3493-8
• Evaluation of exposure and health care worker response to nebulized administration of tgAAVCF to patients with cystic fibrosis. Croteau GA, Martin DB, Camp J, Yost M, Conrad C, Zeitlin PL, Heald AE. Ann Occup Hyg. 2004; 48 (8): 673-81
• Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S, Conrad CK, Brass-Ernst L, Humphries M, Sullivan K, Wetzel R, Taylor G, Carter BJ, Guggino WB. Hum Gene Ther. 2003; 14 (11): 1079-88
• A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Wagner JA, Nepomuceno IB, Messner AH, Moran ML, Batson EP, Dimiceli S, Brown BW, Desch JK, Norbash AM, Conrad CK, Guggino WB, Flotte TR, Wine JJ, Carter BJ, Reynolds TC, Moss RB, Gardner P. Hum Gene Ther. 2002; 13 (11): 1349-59
• Paradoxical vocal cord motion in a child presenting with cyanosis and respiratory failure. Falco DA, Hammer GB, Conrad C, Messner AH. Pediatr Crit Care Med. 2002; 3 (2): 185-186
• Clinical infection control in gene therapy: a multidisciplinary conference. Evans ME, Jordan CT, Chang SM, Conrad C, Gerberding JL, Kaufman HL, Mayhall CG, Nolta JA, Pilaro AM, Sullivan S, Weber DJ, Wivel NA. Infect Control Hosp Epidemiol. 2000; 21 (10): 659-73
• Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Wagner JA, Messner AH, Moran ML, Daifuku R, Kouyama K, Desch JK, Manley S, Norbash AM, Conrad CK, Friborg S, Reynolds T, Guggino WB, Moss RB, Carter BJ, Wine JJ, Flotte TR, Gardner P. Laryngoscope. 1999; 109 (2 Pt 1): 266-74
• A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis. Wagner JA, Moran ML, Messner AH, Daifuku R, Conrad CK, Reynolds T, Guggino WB, Moss RB, Carter BJ, Wine JJ, Flotte TR, Gardner P. Hum Gene Ther. 1998; 9 (6): 889-909
• A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Flotte T, Carter B, Conrad C, Guggino W, Reynolds T, Rosenstein B, Taylor G, Walden S, Wetzel R. Hum Gene Ther. 1996; 7 (9): 1145-59
• In vivo model of adeno-associated virus vector persistence and rescue. Afione SA, Conrad CK, Kearns WG, Chunduru S, Adams R, Reynolds TC, Guggino WB, Cutting GR, Carter BJ, Flotte TR. J Virol. 1996; 70 (5): 3235-41
• Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Conrad CK, Allen SS, Afione SA, Reynolds TC, Beck SE, Fee-Maki M, Barrazza-Ortiz X, Adams R, Askin FB, Carter BJ, Guggino WB, Flotte TR. Gene Ther. 1996; 3 (8): 658-68
• Alveolar stem cell transduction by an adeno-associated viral vector. Zeitlin PL, Chu S, Conrad C, McVeigh U, Ferguson K, Flotte TR, Guggino WB. Gene Ther. 1995; 2 (9): 623-31
• Gene therapy vectors as drug delivery systems. Afione SA, Conrad CK, Flotte TR. Clin Pharmacokinet. 1995; 28 (3): 181-9
• Hemothorax in a child as a result of costal exostosis. Tomares SM, Jabra AA, Conrad CK, Beauchamp N, Phoon CK, Carroll JL. Pediatrics. 1994; 93 (3): 523-5
• Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB, Carter BJ. Proc Natl Acad Sci U S A. 1993; 90 (22): 10613-7
• Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat. Liddle RA, Green GM, Conrad CK, Williams JA. Am J Physiol. 1986; 251 (2 Pt 1): G243-8
• Regulation of gastric emptying in humans by cholecystokinin. Liddle RA, Morita ET, Conrad CK, Williams JA. J Clin Invest. 1986; 77 (3): 992-6